Literature DB >> 27878516

Axonal Excitability in Amyotrophic Lateral Sclerosis : Axonal Excitability in ALS.

Susanna B Park1, Matthew C Kiernan1, Steve Vucic2.   

Abstract

Axonal excitability testing provides in vivo assessment of axonal ion channel function and membrane potential. Excitability techniques have provided insights into the pathophysiological mechanisms underlying the development of neurodegeneration and clinical features of amyotrophic lateral sclerosis (ALS) and related neuromuscular disorders. Specifically, abnormalities of Na+ and K+ conductances contribute to development of membrane hyperexcitability in ALS, thereby leading to symptom generation of muscle cramps and fasciculations, in addition to promoting a neurodegenerative cascade via Ca2+-mediated processes. Modulation of axonal ion channel function in ALS has resulted in significant symptomatic improvement that has been accompanied by stabilization of axonal excitability parameters. Separately, axonal ion channel dysfunction evolves with disease progression and correlates with survival, thereby serving as a potential therapeutic biomarker in ALS. The present review provides an overview of axonal excitability techniques and the physiological mechanisms underlying membrane excitability, with a focus on the role of axonal ion channel dysfunction in motor neuron disease and related neuromuscular diseases.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; axonal excitability; hyperexcitability; ion channels; neurodegeneration; neuromuscular disorders

Mesh:

Substances:

Year:  2017        PMID: 27878516      PMCID: PMC5233634          DOI: 10.1007/s13311-016-0492-9

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  138 in total

1.  The "split hand syndrome".

Authors:  A J Wilbourn
Journal:  Muscle Nerve       Date:  2000-01       Impact factor: 3.217

2.  Pathophysiological insights derived by natural history and motor function of spinal muscular atrophy.

Authors:  Michelle A Farrar; Steve Vucic; Heather M Johnston; Desirée du Sart; Matthew C Kiernan
Journal:  J Pediatr       Date:  2012-07-17       Impact factor: 4.406

3.  Split hand syndrome in amyotrophic lateral sclerosis: different excitability changes in the thenar and hypothenar motor axons.

Authors:  Kazumoto Shibuya; Sonoko Misawa; Saiko Nasu; Yukari Sekiguchi; Satsuki Mitsuma; Minako Beppu; Shigeki Ohmori; Yuta Iwai; Shoichi Ito; Kazuaki Kanai; Yasunori Sato; Satoshi Kuwabara
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-06       Impact factor: 10.154

4.  Distal motor axonal dysfunction in amyotrophic lateral sclerosis.

Authors:  Yu-ichi Noto; Kazuaki Kanai; Sonoko Misawa; Kazumoto Shibuya; Sagiri Isose; Saiko Nasu; Yukari Sekiguchi; Yumi Fujimaki; Masanori Nakagawa; Satoshi Kuwabara
Journal:  J Neurol Sci       Date:  2010-12-31       Impact factor: 3.181

5.  Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS.

Authors:  S Vucic; G A Nicholson; M C Kiernan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-01       Impact factor: 10.154

Review 6.  Axonal ion channels from bench to bedside: a translational neuroscience perspective.

Authors:  Arun V Krishnan; Cindy S-Y Lin; Susanna B Park; Matthew C Kiernan
Journal:  Prog Neurobiol       Date:  2009-08-21       Impact factor: 11.685

7.  Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis.

Authors:  Benjamin C Cheah; Cindy S Y Lin; Susanna B Park; Steve Vucic; Arun V Krishnan; Matthew C Kiernan
Journal:  Clin Neurophysiol       Date:  2012-08-23       Impact factor: 3.708

8.  Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage.

Authors:  Kazuaki Kanai; Satoshi Kuwabara; Sonoko Misawa; Noriko Tamura; Kazue Ogawara; Miho Nakata; Setsu Sawai; Takamichi Hattori; Hugh Bostock
Journal:  Brain       Date:  2006-02-08       Impact factor: 13.501

9.  Upregulation of persistent sodium conductances in familial ALS.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-09-02       Impact factor: 10.154

10.  Early intrinsic hyperexcitability does not contribute to motoneuron degeneration in amyotrophic lateral sclerosis.

Authors:  Félix Leroy; Boris Lamotte d'Incamps; Rebecca D Imhoff-Manuel; Daniel Zytnicki
Journal:  Elife       Date:  2014-10-14       Impact factor: 8.140

View more
  15 in total

1.  Functional up-regulation of the M-current by retigabine contrasts hyperexcitability and excitotoxicity on rat hypoglossal motoneurons.

Authors:  Filippo Ghezzi; Laura Monni; Andrea Nistri
Journal:  J Physiol       Date:  2018-05-30       Impact factor: 5.182

2.  An Appraisal of Novel Biomarkers for Evaluating and Monitoring Neurologic Diseases: Editorial Introduction.

Authors:  Jeremy M Shefner; Marwan N Sabbagh
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

3.  In vivo evidence for reduced ion channel expression in motor axons of patients with amyotrophic lateral sclerosis.

Authors:  James Howells; José Manuel Matamala; Susanna B Park; Nidhi Garg; Steve Vucic; Hugh Bostock; David Burke; Matthew C Kiernan
Journal:  J Physiol       Date:  2018-10-17       Impact factor: 5.182

Review 4.  Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.

Authors:  Alexander Starr; Rita Sattler
Journal:  Brain Res       Date:  2018-02-14       Impact factor: 3.252

5.  Ion channel dysfunction and altered motoneuron excitability in ALS.

Authors:  Eric LoRusso; James J Hickman; Xiufang Guo
Journal:  Neurol Disord Epilepsy J       Date:  2019-07-30

Review 6.  Ionic Homeostasis Maintenance in ALS: Focus on New Therapeutic Targets.

Authors:  Rossana Sirabella; Valeria Valsecchi; Serenella Anzilotti; Ornella Cuomo; Antonio Vinciguerra; Pasquale Cepparulo; Paola Brancaccio; Natascia Guida; Nicolas Blondeau; Lorella M T Canzoniero; Cristina Franco; Salvatore Amoroso; Lucio Annunziato; Giuseppe Pignataro
Journal:  Front Neurosci       Date:  2018-08-07       Impact factor: 4.677

7.  Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression.

Authors:  Ingrid S Tarr; Emily P McCann; Beben Benyamin; Timothy J Peters; Natalie A Twine; Katharine Y Zhang; Qiongyi Zhao; Zong-Hong Zhang; Dominic B Rowe; Garth A Nicholson; Denis Bauer; Susan J Clark; Ian P Blair; Kelly L Williams
Journal:  Sci Rep       Date:  2019-06-04       Impact factor: 4.379

Review 8.  Biomarkers in Motor Neuron Disease: A State of the Art Review.

Authors:  Nick S Verber; Stephanie R Shepheard; Matilde Sassani; Harry E McDonough; Sophie A Moore; James J P Alix; Iain D Wilkinson; Tom M Jenkins; Pamela J Shaw
Journal:  Front Neurol       Date:  2019-04-03       Impact factor: 4.003

Review 9.  Ryanodine Receptors: A Potential Treatment Target in Various Neurodegenerative Disease.

Authors:  Liang Sun; Huafeng Wei
Journal:  Cell Mol Neurobiol       Date:  2020-08-24       Impact factor: 5.046

10.  Human amyotrophic lateral sclerosis excitability phenotype screen: Target discovery and validation.

Authors:  Xuan Huang; Kasper C D Roet; Liying Zhang; Amy Brault; Allison P Berg; Anne B Jefferson; Jackie Klug-McLeod; Karen L Leach; Fabien Vincent; Hongying Yang; Anthony J Coyle; Lyn H Jones; Devlin Frost; Ole Wiskow; Kuchuan Chen; Rie Maeda; Alyssa Grantham; Mary K Dornon; Joseph R Klim; Marco T Siekmann; Dongyi Zhao; Seungkyu Lee; Kevin Eggan; Clifford J Woolf
Journal:  Cell Rep       Date:  2021-06-08       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.